Lamivudine is effective for preventing or delaying occurrence of liver failure and HCC through lowering HBV, and therefore can be a first choice drug for patients with high HBV levels regardless of serum ALT levels. The gene discussed is GPT; the disease is hepatocellular carcinoma.